Naomi Seresinhe
Directeur des opérations chez Cytovance Biologics, Inc.
Provenance du réseau au premier degré de Naomi Seresinhe
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK.
4
| Subsidiary | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Naomi Seresinhe via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity | |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Chairman | ||
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Wholesale Distributors | Chairman | |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | Chairman | ||
| Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Board Member | ||
Shenzhen Leren Technology Co. Ltd.
 Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Information Technology Services | Director/Board Member | |
| Vanderbilt University | College/University | Undergraduate Degree | |
| Sichuan University | College/University | Undergraduate Degree | |
UBS AG (Hong Kong Branch)
 UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Yunfeng Capital Co. Ltd. | Corporate Officer/Principal | ||
Sieger Healthcare Acquisition Corp.
 Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Financial Conglomerates | Chief Executive Officer | |
Bombax Healthcare Acquisition Corp.
 Bombax Healthcare Acquisition Corp. Financial ConglomeratesFinance Bombax Healthcare Acquisition Corp. is a blank check company. It engages in the business of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was founded on June 11, 2021 and is headquartered in Singapore. | Financial Conglomerates | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| HIGHTIDE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Chine | 10 |
| Etats-Unis | 6 |
| Îles Cayman | 3 |
| Hong Kong | 2 |
Sectorielle
| Finance | 5 |
| Consumer Services | 5 |
| Health Technology | 4 |
| Distribution Services | 2 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 9 |
| Chairman | 9 |
| Undergraduate Degree | 3 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Xuan Sun | 10 |
| Li Li | 10 |
| Bin Zhang | 2 |
| Anne Garstka | 1 |
- Bourse
- Insiders
- Naomi Seresinhe
- Connexions Sociétés
